120+ M
SHL Medical autoinjectors reach patients worldwide in a year.
And we are growing capacity to reach more patients year by year.
We design and manufacture advanced self-injection solutions, including autoinjectors, pen injectors, and systems for large-volume and high-viscosity formulations. Since 1989, we have transformed drug delivery through groundbreaking innovations.
As demand for self-treatment and personalized healthcare grows, we create reliable, cost-efficient, and patient-focused devices. Partnering with leading pharma and biotech companies, we deliver solutions that enhance patients’ independence and quality of life.
With decades of global experience, we provide agile support at every stage – from concept to market-ready products – pioneering the future of self-treatment therapies
We support you through every stage of development and production, providing tailored solutions and expert insights. Our modular device development strategy, refined over years, ensures the lasting value of self-injection systems designed in collaboration with our customers. In combination product development, we address varied device needs by leveraging our platform offerings and end-to-end services—from research and testing to regulatory filings and final assembly. This integrated approach ensures a smooth and reliable experience, meeting the highest demands of our pharma and biotech partners.
We help customers assess their drug and primary packaging compatibility through functional testing and dimension analysis, reducing costly risks and optimizing package selection.
Our constant pursuit of contemporary yet innovative designs in drug delivery technologies is a cornerstone of our success. From concept development to human factors engineering, our competencies ensure user-centric designs.
We collaborate with the top 25 pharma and biotech companies to develop innovative devices, leveraging scientific principles and extensive product development expertise in design, testing, and manufacturing.
Our in-house manufacturing enables flexible, scalable solutions that meet customer needs throughout the product lifecycle. We accelerate time-to-market with tailored support and integrated processes for efficient production and assembly.
We have delivered hundreds of millions of self-injection devices to patients, supporting both established and novel treatments in the industry. We are committed to expanding our global manufacturing operations and exploring new markets with our partners.
We offer final assembly, labeling, and packaging services in the US and in Europe through our alliance partners. Our Deerfield Beach site provides equipment qualification, process development, and turnkey solutions, along with labeling, packaging, and serialization.
Our quality, regulatory, and supply chain expertise is fully integrated into each device project to fulfill clinical, commercial, and aftermarket needs.
SHL Medical’s self-injection device platforms offer standardized designs that can be customized to meet specific needs, supported by our comprehensive in-house manufacturing infrastructure. This approach accelerates development timelines, minimizes investment risks, and ensures scalability for low- or high-volume production. With over 30 years of expertise, we provide future-proof technologies addressing connectivity and sustainability demands. Backed by a robust patent portfolio, our platforms ensure a safe, reliable injection experience that enhances patient confidence.
We have dedicated years of expertise, commitment, and resources to developing world-class healthcare solutions that empower people. The Molly® Connected Cap and Elexy™ are the latest additions in our portfolio.
Upon removal from the Molly® device, the Connected Cap becomes active, allowing timestamped data to be relayed through a smart data transmission hub and to the cloud.
Elexy™ aims to provide a best-in-class user experience and a wide range of injection profiles. Comprised of a reusable power unit and disposable drug cassettes, the Elexy system is compatible with both pre-filled syringe (PFS) and cartridge primary containers and, capable of delivering up to 5.0 mL in a single injection.